Concepedia

Publication | Open Access

A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy

DOIFull Paper Access

25

Citations

18

References

2014

Year

Kentaro Fujiwara, Keitaro Koyama, Kousuke Suga, Masako Ikemura, Yasutaka Saito, Akihiro Hino, Hiroko Iwanari, Osamu Kusano‐Arai, Kenichi Mitsui, Hiroyuki Kasahara,
EJNMMI Research

Abstract

These results suggest that RIT with (90)Y-anti-ROBO1 MAb is a promising treatment for ROBO1-positive hepatocellular carcinoma.

References

YearCitations

Page 1